Director Share Dealings - Nuvectis Pharma Inc (NVCT)

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

≈ Figures for the value of trade may not add up due to rounding.

Recent deals

Date	Name and position (if held)	Deal type	Number of shares dealt	Price per share	Value of trade ≈	Shares remaining
30 June 2026	Ronald E. (Ron) BentsurChairman/CEO	Buy Regular purchase transaction	12,500	$20.00	$250,000.00	3,688,424
30 June 2026	Marlio Charles Mosseri10% Owner	Buy Regular purchase transaction	50,000	$18.32	$916,000.00	3,186,576

End of results. Director deals are only available for the last 12 months.

5 most significant deals

Date	Name and position (if held)	Deal type	Number of shares dealt	Price per share	Value of trade ≈	Shares remaining
30 June 2026	Marlio Charles Mosseri10% Owner	Buy Regular purchase transaction	50,000	$18.32	$916,000.00	3,186,576
30 June 2026	Ronald E. (Ron) BentsurChairman/CEO	Buy Regular purchase transaction	12,500	$20.00	$250,000.00	3,688,424

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.